Welcome to our dedicated page for Elanco Animal Health news (Ticker: ELAN), a resource for investors and traders seeking the latest updates and insights on Elanco Animal Health stock.
Elanco Animal Health develops, manufactures and markets animal health products for farm animals and pets. News about ELAN commonly covers operating and financial results, product launches in pet health and livestock health, and regulatory actions involving animal medicines and parasite-control products.
Company updates also include capital-structure disclosures, investor conference presentations, and governance changes tied to Elanco's board and public-company operations. Product-specific developments have included the Advantage brand for dogs and emergency-authorized livestock treatments such as Negasunt Powder and Tanidil.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Elanco Animal Health Incorporated (NYSE: ELAN) will disclose its first quarter 2023 financial results on May 9, 2023. The company will hold a conference call at 8:00 a.m. eastern time to discuss its performance with investors and media. A live webcast of the call can be accessed via a link on Elanco's website, with a replay available shortly after. Elanco focuses on delivering products and services aimed at preventing and treating diseases in animals. With a legacy of nearly 70 years, the company aims to enhance the health of animals and contribute positively to communities.
Athian, the first cloud-based carbon marketplace for the livestock industry, has secured a seed investment from Tyson Ventures, aiming to enhance sustainability practices in livestock farming. This investment, alongside previous funding from Elanco Animal Health and Newtrient LLC, will expedite the launch of a unique carbon credit inset program designed to reward farmers for measurable greenhouse gas reductions. Athian’s platform is set to go live in the second half of 2023, allowing livestock producers to monetize their sustainability efforts while contributing to climate change mitigation.
Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the Barclays Global Healthcare Conference on March 14-15, 2023. The company's CFO, Todd Young, is set to engage in a fireside chat on March 14 at 8:30 a.m. ET. A live audio webcast of the event can be accessed via the 'Events and Presentations' section on Elanco's investor website, with a replay available for 30 days.
Elanco, a leader in animal health, focuses on innovative solutions for farm animals and pets, committed to improving animal health and community impact.
Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the Cowen 43rd Annual Health Care Conference on March 6-7, 2023. Jeff Simmons, the president and CEO, is scheduled for a fireside chat on March 6 at 2:10 p.m. ET. A live audio webcast will be available in the 'Events and Presentations' section of Elanco's investor website, with a replay available for about 30 days.
Elanco is dedicated to improving animal health, with nearly 70 years of experience in delivering effective products and services for farm animals and pets.